These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6621727)

  • 21. [Myocardial infarct--is prevention possible?].
    Nicolaysen R
    Nord Med; 1971 Apr; 85(15):472-4. PubMed ID: 5574986
    [No Abstract]   [Full Text] [Related]  

  • 22. [Ximelagatran, an oral thrombin inhibitor without the need for regular monitoring of the anticoagulant status].
    Tieleman RG
    Ned Tijdschr Geneeskd; 2003 Oct; 147(42):2046-8. PubMed ID: 14606349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of antiplatelet agents and anticoagulants in post-myocardial infarction.
    Fiore LD; Deykin D
    Cardiol Clin; 1994 Aug; 12(3):451-76. PubMed ID: 7805079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral anticoagulant therapy in the chronic phase of myocardial infarction.
    Smith P
    Arch Pathol Lab Med; 1993 Jan; 117(1):97-101. PubMed ID: 8418770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impending myocardial infarction: the value of anticoagulant therapy.
    Master AM
    GP; 1965 Oct; 32(4):122-33. PubMed ID: 5827886
    [No Abstract]   [Full Text] [Related]  

  • 26. [Anticoagulant or antiaggregant therapy in the secondary prevention of myocardial infarct?].
    De Caterina R; Gianetti J; Simonetti I; Gensini G
    G Ital Cardiol; 1996 Nov; 26(11):1309-21. PubMed ID: 9036028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Myocardial infarct: anticoagulation and thrombolysis].
    Trenkwalder P; Lydtin H
    Dtsch Med Wochenschr; 1993 Mar; 118(10):359-60. PubMed ID: 8453905
    [No Abstract]   [Full Text] [Related]  

  • 28. [Anticoagulants and thrombocyte aggregation inhibitors in the treatment of heart infarct. A survey].
    Spitzer W; Durst OE; Lang E
    Fortschr Med; 1983 Jan; 101(1-2):22-30. PubMed ID: 6826125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risks of oral anticoagulant therapy with increasing age.
    Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [What can be done to prevent myocardial infarct].
    Poppi A
    Actual Cardiol Angeiol Int (Paris); 1965; 14(4):267-72. PubMed ID: 5879745
    [No Abstract]   [Full Text] [Related]  

  • 31. [Anticoagulant therapy and peripheral arteriosclerosis].
    van Vroonhoven TJ; de Smit P
    Ned Tijdschr Geneeskd; 1979 Dec; 123(52):226-9. PubMed ID: 545162
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical impact of local implementation of agreed guidelines for the management of patients with acute myocardial infarction.
    Badano L; Cassin M; Solinas L; Burelli C; Macor F; Zanuttini D
    G Ital Cardiol; 1999 Jan; 29(1):39-47. PubMed ID: 9987046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Methodology of exercise tests in the 1st month of acute myocardial infarct].
    Aros LF; Loma-Osorio A; San José JM; Cordo JC; Camacho I; Pajarón A
    Rev Esp Cardiol; 1981; 34(2):127-32. PubMed ID: 7291658
    [No Abstract]   [Full Text] [Related]  

  • 34. E.P.S.I.M., the French oral anticoagulant--aspirin trial in post-myocardial infarction patients: design, organization and quality control procedures.
    Boissel JP; Leizorovicz A; Schbath J; Destors JM; Gillet J
    Scand J Haematol Suppl; 1981; 38():47-72. PubMed ID: 7038857
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pro and con: Anticoagulation or thrombocyte function inhibitors in the prophylaxis of myocardial infarct? Arguments in favor of anticoagulation].
    Loeliger EA
    Internist (Berl); 1980 Jul; 21(7):397-8. PubMed ID: 7007280
    [No Abstract]   [Full Text] [Related]  

  • 36. [Myocardial infarct: sex-specific differences in symptoms and risk factors. In women sugar weighs heavier].
    MMW Fortschr Med; 2004 Nov; 146(45):16-7. PubMed ID: 15581098
    [No Abstract]   [Full Text] [Related]  

  • 37. [Problems associated with long-term anticoagulant therapy (author's transl)].
    Servais J; De Greef C; Dernier P
    Acta Chir Belg; 1980; 79(1):15-9. PubMed ID: 7368887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effectiveness of the rehabilitative treatment and prolonged dispensary observation of patients who have had a myocardial infarct].
    Kuz'ko NV
    Vrach Delo; 1980 Oct; (10):9-13. PubMed ID: 7434716
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study on secondary prevention of myocardial infarct (EPSIM). Work of the EPSIM research group].
    Arch Mal Coeur Vaiss; 1982 Dec; 75 Spec No():1-130. PubMed ID: 6820624
    [No Abstract]   [Full Text] [Related]  

  • 40. [Long-term anticoagulant treatment after acute heart infarct].
    CLAUSEN J
    Nord Med; 1962 Dec; 68():1622-3. PubMed ID: 14021617
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.